Brief: Abbisko Cayman Says IND Approval By NMPA Obtained For Absk112
27/10/2023 02:33
Oct 27 (Reuters) - Abbisko Cayman Ltd 2256.HK :
* IND APPROVAL BY NMPA OBTAINED FOR ABSK112
Further company coverage: 2256.HK
Recent news on Abbisko Medicine
See all newsChina's Abbisko jumps on positive clinical trial results for achondroplasia drug
Brief: Abbisko Cayman Says Unit Completes First Patient Dosing In Phase I Trial Of ABSK211
Brief: Abbisko Cayman Gets IND Clearance From FDA For Oral Small Molecule Pan-Kras Inhibitor ABSK211
HK-listed Abbisko hits 7-week peak on AstraZeneca tie-up
Brief: Abbisko Therapeutics And Astrazeneca Enter A Strategic Collaboration